Canada Life
KRYS icon

Canada Life’s Krystal Biotech KRYS Stock Holding History

Canada Life’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.53M Sell
21,413
-674
-3% -$179K 0.01% 704
2025
Q4 		$5.45M Buy
22,087
+689
+3% +$145K 0.01% 712
2025
Q3 		$3.78M Buy
21,398
+551
+3% +$82.5K 0.01% 947
2025
Q2 		$2.86M Sell
20,847
-3,762
-15% -$553K ﹤0.01% 1036
2025
Q1 		$4.43M Sell
24,609
-2,145
-8% -$361K 0.01% 840
2024
Q4 		$4.19M Sell
26,754
-22
-0.1% -$3.9K 0.01% 928
2024
Q3 		$4.87M Sell
26,776
-597
-2% -$115K 0.01% 880
2024
Q2 		$5.03M Buy
27,373
+24,245
+775% +$4.07M 0.01% 824
2024
Q1 		$557K Buy
3,128
+1,397
+81% +$194K ﹤0.01% 1667
2023
Q4 		$213K Hold
1,731
– – ﹤0.01% 1836
2023
Q3 		$201K Buy
1,731
+1,040
+151% +$127K ﹤0.01% 1858
2023
Q2 		$82K Sell
691
-55
-7% -$5.62K ﹤0.01% 1945
2023
Q1 		$60K Sell
746
-267
-26% -$21K ﹤0.01% 2042
2022
Q4 		$81K Hold
1,013
– – ﹤0.01% 2014
2022
Q3 		$70K Hold
1,013
– – ﹤0.01% 2049
2022
Q2 		$67K Hold
1,013
– – ﹤0.01% 1991
2022
Q1 		$72K Buy
1,013
+346
+52% +$21.6K ﹤0.01% 2080
2021
Q4 		$47K Hold
667
– – ﹤0.01% 2188
2021
Q3 		$35K Hold
667
– – ﹤0.01% 2322
2021
Q2 		$45K Sell
667
-338
-34% -$23.6K ﹤0.01% 2303
2021
Q1 		$77K Buy
1,005
+395
+65% +$28.7K ﹤0.01% 2166
2020
Q4 		$36K Hold
610
– – ﹤0.01% 2392
2020
Q3 		$26K Hold
610
– – ﹤0.01% 2377
2020
Q2 		$25K Hold
610
– – ﹤0.01% 2443
2020
Q1 		$27K Hold
610
– – ﹤0.01% 2310
2019
Q4 		$33K Hold
610
– – ﹤0.01% 2397
2019
Q3 		$21K Sell
610
-1,210
-66% -$54.1K ﹤0.01% 1077
2019
Q2 		$73K Buy
+1,820
New +$59.5K ﹤0.01% 2323

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Canada Life's KRYS Position: Q1 2026 in Review

Canada Life reduced its Krystal Biotech (KRYS) stake by 3.1% in Q1 2026, selling an estimated $179K and leaving 21,413 shares worth $5.53M. The position accounts for 0.01% of the portfolio, ranked #704.

Canada Life first reported a position in KRYS in Q2 2019 and has held it in 28 quarters since. 367 funds tracked by Wall St. Rank hold KRYS as of Q1 2026.

  • Canada Life held 21,413 shares of Krystal Biotech worth $5.53M as of Q1 2026.
  • Canada Life sold 674 Krystal Biotech shares in Q1 2026, an estimated $179K.
  • Krystal Biotech made up 0.01% of Canada Life's portfolio in Q1 2026, its #704 holding.
  • Canada Life first reported a position in Krystal Biotech in Q2 2019 and has held it in 28 quarters since.
  • 367 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.